Expertise in
25
conditions

Dr. Nimish Mohile

Neurology
U Of R Neurology Department
601 Elmwood Ave, 
Rochester, NY 
Offers Telehealth
Expertise in
25
conditions
U Of R Neurology Department
601 Elmwood Ave, 
Rochester, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Nimish Mohile is a Neurologist in Rochester, New York. Dr. Mohile is highly rated in 25 conditions, according to our data. His top areas of expertise are Astrocytoma, Glioblastoma, Glioma, and Brain Tumor.

His clinical research consists of co-authoring 71 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
Psychiatry & Neurology in NY
Hospital Affiliations
Strong Memorial Hospital
F F Thompson Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Geisinger
  • HMO
  • POS
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MVP Health
  • EPO
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 5 Less Insurance Carriers -

Locations

U OF R NEUROLOGY DEPARTMENT
601 Elmwood Ave, Rochester, NY 14642
Other Locations
U OF R NEUROLOGY DEPARTMENT
601 Elmwood Ave Box, Rochester, NY 14642

Additional Areas of Focus

Dr. Mohile has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
A Phase 3 Randomized Double-blind, Controlled Study of ICT-107 With Maintenance Temozolomide (TMZ) in Newly Diagnosed Glioblastoma Following Resection and Concomitant TMZ Chemoradiotherapy
Enrollment Status: Suspended
Publish Date: April 03, 2024
Intervention Type: Biological
Study Phase: Phase 3
Phase 1/2 Dose-Escalation Study of TPI 287 in Combination With Bevacizumab Followed by Randomized Study of the Maximum Tolerated Dose of TPI 287 in Combination With Bevacizumab Versus Bevacizumab Alone in Adults With Recurrent Glioblastoma
Phase 1/2 Dose-Escalation Study of TPI 287 in Combination With Bevacizumab Followed by Randomized Study of the Maximum Tolerated Dose of TPI 287 in Combination With Bevacizumab Versus Bevacizumab Alone in Adults With Recurrent Glioblastoma
Enrollment Status: Suspended
Publish Date: February 22, 2023
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

71 Total Publications

Quality measurements in neuro-oncology: A critical look at glioblastoma indicators and the path forward.
Quality measurements in neuro-oncology: A critical look at glioblastoma indicators and the path forward.
Journal: Neuro-oncology practice
Published: October 13, 2025
Similar Doctors
Expertise in
17
conditions
Dr. Benzi M. Kluger
Neurology
Expertise in
17
conditions
Dr. Benzi M. Kluger
Neurology

University Of Rochester

601 Elmwood Ave, Box 684, 
Rochester, NY 
 (0.1 miles away)
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Benzi Kluger is a Neurologist in Rochester, New York. Dr. Kluger is highly rated in 17 conditions, according to our data. His top areas of expertise are Parkinson's Disease, Movement Disorders, Supranuclear Ophthalmoplegia, Progressive Supranuclear Palsy, and Gastrostomy.

Expertise in
17
conditions
Dr. Chad R. Heatwole
Neurology
Expertise in
17
conditions
Dr. Chad R. Heatwole
Neurology

University Of Rochester

601 Elmwood Ave, 
Rochester, NY 
 (0.1 miles away)
585-275-2100
Languages Spoken:
English
See accepted insurances

Chad Heatwole is a Neurologist in Rochester, New York. Dr. Heatwole is highly rated in 17 conditions, according to our data. His top areas of expertise are Myotonic Dystrophy, Myotonic Dystrophy Type 2, Paramyotonia Congenita, and Facioscapulohumeral Muscular Dystrophy (FSHD).

Expertise in
34
conditions
Dr. Emma Ciafaloni
Neurology
Expertise in
34
conditions
Dr. Emma Ciafaloni
Neurology

University Of Rochester

738 Library Rd, 
Rochester, NY 
 (0.4 miles away)
585-275-2638
Languages Spoken:
English
See accepted insurances

Emma Ciafaloni is a Neurologist in Rochester, New York. Dr. Ciafaloni is highly rated in 34 conditions, according to our data. Her top areas of expertise are Becker Muscular Dystrophy, Duchenne Muscular Dystrophy, Myasthenia Gravis, Spinal Muscular Atrophy (SMA), and Thymectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mohile's expertise for a condition
ConditionClose
View All 11 Distinguished Conditions
View All 9 Advanced Conditions
View All 24 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile